3V2640-CLIN-005 A Phase 2, Multi-Center, Single-Blind, Randomized Placebo Controlled Study of TVB-2640 in Subjects with Non-Alcoholic Steatohepatitis

Administered By

Contributors

Start/End

  • May 31, 2019 - May 30, 2020